Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
Status:
RECRUITING
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
The MODIFY CSX study is a prospective, randomized, placebo-controlled trial conducted in heart centers in Germany.
A total of 120 high-risk cardiac surgery patients will receive either 0.20 g fish oil/kg body weight (BW) + standard of care versus same volume of placebo (NaCl) + standard of care.
Phase:
PHASE2
Details
Lead Sponsor:
GCP-Service International West GmbH
Collaborators:
Charite University, Berlin, Germany Johannes Gutenberg University Mainz Universitätsklinikum Hamburg-Eppendorf University Hospital Augsburg University Hospital Goettingen University Hospital Muenster University Hospital Schleswig-Holstein University Hospital, Bonn Wuerzburg University Hospital